scholarly journals Skeletal Muscle Cells Generated from Pluripotent Stem Cells

2017 ◽  
Vol 2017 ◽  
pp. 1-2 ◽  
Author(s):  
Yuko Miyagoe-Suzuki ◽  
Atsushi Asakura ◽  
Masatoshi Suzuki
2017 ◽  
Vol 2017 ◽  
pp. 1-16 ◽  
Author(s):  
Yusaku Kodaka ◽  
Gemachu Rabu ◽  
Atsushi Asakura

Embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) have the potential to differentiate into various types of cells including skeletal muscle cells. The approach of converting ESCs/iPSCs into skeletal muscle cells offers hope for patients afflicted with the skeletal muscle diseases such as the Duchenne muscular dystrophy (DMD). Patient-derived iPSCs are an especially ideal cell source to obtain an unlimited number of myogenic cells that escape immune rejection after engraftment. Currently, there are several approaches to induce differentiation of ESCs and iPSCs to skeletal muscle. A key to the generation of skeletal muscle cells from ESCs/iPSCs is the mimicking of embryonic mesodermal induction followed by myogenic induction. Thus, current approaches of skeletal muscle cell induction of ESCs/iPSCs utilize techniques including overexpression of myogenic transcription factors such as MyoD or Pax3, using small molecules to induce mesodermal cells followed by myogenic progenitor cells, and utilizing epigenetic myogenic memory existing in muscle cell-derived iPSCs. This review summarizes the current methods used in myogenic differentiation and highlights areas of recent improvement.


2020 ◽  
Vol 7 (4) ◽  
pp. 395-405
Author(s):  
Takahiko Sato

Induced pluripotent stem cells (iPSCs) have the potential to differentiate into various types of cells and tissues including skeletal muscle. The approach to convert these stem cells into skeletal muscle cells offers hope for patients afflicted with skeletal muscle diseases such as Duchenne muscular dystrophy (DMD). Several methods have been reported to induce myogenic differentiation with iPSCs derived from myogenic patients. An important point for generating skeletal muscle cells from iPSCs is to understand in vivo myogenic induction in development and regeneration. Current protocols of myogenic induction utilize techniques with overexpression of myogenic transcription factors such as Myod1(MyoD), Pax3, Pax7, and others, using recombinant proteins or small molecules to induce mesodermal cells followed by myogenic progenitors, and adult muscle stem cells. This review summarizes the current approaches used for myogenic induction and highlights recent improvements.


2014 ◽  
Vol 4 (7) ◽  
pp. 579-585 ◽  
Author(s):  
Tannaz Norizadeh-Abbariki ◽  
Omid Mashinchian ◽  
Mohammad Ali Shokrgozar ◽  
Nooshin Haghighipour ◽  
Tapas Sen ◽  
...  

Cell Reports ◽  
2013 ◽  
Vol 3 (3) ◽  
pp. 661-670 ◽  
Author(s):  
Sonia Albini ◽  
Paula Coutinho ◽  
Barbora Malecova ◽  
Lorenzo Giordani ◽  
Alex Savchenko ◽  
...  

2016 ◽  
Vol 24 (9) ◽  
pp. 1550-1560 ◽  
Author(s):  
SooJin Kwon ◽  
Soo Mi Ki ◽  
Sang Eon Park ◽  
Min-Jeong Kim ◽  
Brian Hyung ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document